171 related articles for article (PubMed ID: 10967277)
1. Management strategies for heparin-induced thrombocytopenia in heart-transplant candidates: case report and review of the literature.
Pamboukian SV; Ignaszewski AP; Ross HJ
J Heart Lung Transplant; 2000 Aug; 19(8):810-4. PubMed ID: 10967277
[TBL] [Abstract][Full Text] [Related]
2. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
Olin DA; Urdaneta F; Lobato EB
J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
[No Abstract] [Full Text] [Related]
3. The management of heparin-induced thrombocytopenia.
Keeling D; Davidson S; Watson H;
Br J Haematol; 2006 May; 133(3):259-69. PubMed ID: 16643427
[TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
[No Abstract] [Full Text] [Related]
5. Heparin-induced thrombocytopenia: what clinicians need to know.
Chong BH; Isaacs A
Thromb Haemost; 2009 Feb; 101(2):279-83. PubMed ID: 19190810
[No Abstract] [Full Text] [Related]
6. Current agents for the treatment of patients with heparin-induced thrombocytopenia.
Warkentin TE
Curr Opin Pulm Med; 2002 Sep; 8(5):405-12. PubMed ID: 12172444
[TBL] [Abstract][Full Text] [Related]
7. Treatment of heparin-induced thrombocytopenia.
Peters FP
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
[No Abstract] [Full Text] [Related]
8. Heparin-induced thrombocytopenia presenting after the cessation of low molecular weight heparin prophylaxis with enoxaparin.
Barratt SM; Ruff SJ; Edwards RC
Med J Aust; 2000 May; 172(9):449. PubMed ID: 10870540
[No Abstract] [Full Text] [Related]
9. [Heparin-induced thrombocytopenia].
Christoffersen C; Lethagen S; Gøtze JP
Ugeskr Laeger; 2009 Feb; 171(8):612-5. PubMed ID: 19284907
[TBL] [Abstract][Full Text] [Related]
10. Heparin-induced thrombocytopenia type II: successful use of Orgaran (ORG 10172) in intensive care patients.
Burkhard-Meier U; Söhngen D; Schultheiss HP; Greinacher A; Schwartzkopff B; Vogt M; Heyll A; Schneider W
Intensive Care Med; 1995 Jun; 21(6):542-3. PubMed ID: 7560499
[No Abstract] [Full Text] [Related]
11. Heparinoid anticoagulation and topical fibrin sealant in heparin-induced thrombocytopenia.
Jackson MR; Danby CA; Alving BM
Ann Thorac Surg; 1997 Dec; 64(6):1815-7. PubMed ID: 9436582
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary bypass in patients with heparin-induced thrombocytopenia using Org 10172.
Wilhelm MJ; Schmid C; Kececioglu D; Möllhoff T; Ostermann H; Scheld HH
Ann Thorac Surg; 1996 Mar; 61(3):920-4. PubMed ID: 8619718
[TBL] [Abstract][Full Text] [Related]
13. Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Saxon BR; Black MD; Edgell D; Noel D; Leaker MT
Ann Thorac Surg; 1999 Sep; 68(3):1076-8. PubMed ID: 10510017
[TBL] [Abstract][Full Text] [Related]
14. Heparin induced thrombocytopenia. Experiences in 12 heart surgery patients.
Sodian R; Loebe M; Gorman KF; Riess H; Hetzer R
ASAIO J; 1997; 43(5):M430-3. PubMed ID: 9360077
[TBL] [Abstract][Full Text] [Related]
15. Danaparoid for cardiopulmonary bypass in patients with previous heparin-induced thrombocytopenia.
Gillis S; Merin G; Zahger D; Deeb M; Drenger B; Hyam E; Eldor A
Br J Haematol; 1997 Sep; 98(3):657-9. PubMed ID: 9332322
[TBL] [Abstract][Full Text] [Related]
16. Delayed thrombin generation with hirudin anticoagulation during prolonged cardiopulmonary bypass.
Rubens FD; Lavalee G; Ruel MA; Mesana T; Bourke M
Ann Thorac Surg; 2005 Jan; 79(1):334-6. PubMed ID: 15620975
[TBL] [Abstract][Full Text] [Related]
17. [Cardiac surgery in patients with heparin-induced thrombocytopenia (HIT II)].
Jović MD; Nezić DG; Calija BM; Nenadić DS; Knezević AM; Borzanović MD; Krivokapić BM; Petrović IM; Djukanović BP
Acta Chir Iugosl; 2009; 56(1):47-52. PubMed ID: 19504989
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
19. Coronary artery bypass grafting in a patient with type II heparin associated thrombopenia.
Christiansen S; Geiger A; Splittgerber FH; Reidemeister JC
Cardiovasc Surg; 1998 Feb; 6(1):90-3. PubMed ID: 9546852
[TBL] [Abstract][Full Text] [Related]
20. Heparin-induced thrombocytopenia in paediatric patients--a review of the literature and a new case treated with danaparoid sodium.
Ranze O; Ranze P; Magnani HN; Greinacher A
Eur J Pediatr; 1999 Dec; 158 Suppl 3():S130-3. PubMed ID: 10650852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
